The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

Rumors Linking Yung Miami to HIV Diagnosis Proven False A wave of concern and confusion hit social media this weekend. […] ...

A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt ...

Today, Pride is still an uprising. Keeping HIV awareness and prevention at the heart of Pride Month deepens its mission and ...

Global health advocates are concerned that the U.S. is halting support for the the Gavi program that immunized roughly 1.1 ...

HIV/Aids breakthrough not a 'cure', popular social media posts misrepresent the factsIN SHORT: While promising, a recent breakthrough in HIV research is not a "cure" or a "vaccine", as several posts ...

The WHO issued a global recommendation for lenacapavir, a highly effective, twice-yearly injection to prevent HIV infection.

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of preventive management than in the general population.

Mike McCune said the Gates Foundation is “doubling down” on finding a cure for HIV during an ASGCT symposium.